Titre : Formamides

Formamides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Collection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Formamides : Questions médicales les plus fréquentes", "headline": "Formamides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Formamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-21", "dateModified": "2025-04-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Formamides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Formiates", "url": "https://questionsmedicales.fr/mesh/D005561", "about": { "@type": "MedicalCondition", "name": "Formiates", "code": { "@type": "MedicalCode", "code": "D005561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.081.420" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N,N-Diméthyl-formamide", "alternateName": "Dimethylformamide", "url": "https://questionsmedicales.fr/mesh/D004126", "about": { "@type": "MedicalCondition", "name": "N,N-Diméthyl-formamide", "code": { "@type": "MedicalCode", "code": "D004126", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.081.420.500.387" } } } ], "about": { "@type": "MedicalCondition", "name": "Formamides", "alternateName": "Formamides", "code": { "@type": "MedicalCode", "code": "D005559", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Gang Feng", "url": "https://questionsmedicales.fr/author/Gang%20Feng", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Chemical Engineering, Chongqing University, Daxuecheng South Rd. 55, 401331 Chongqing, China." } }, { "@type": "Person", "name": "Martin Ferus", "url": "https://questionsmedicales.fr/author/Martin%20Ferus", "affiliation": { "@type": "Organization", "name": "J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, CZ 18223 Prague 8, Czech Republic." } }, { "@type": "Person", "name": "Raffaele Saladino", "url": "https://questionsmedicales.fr/author/Raffaele%20Saladino", "affiliation": { "@type": "Organization", "name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy." } }, { "@type": "Person", "name": "Ernesto Di Mauro", "url": "https://questionsmedicales.fr/author/Ernesto%20Di%20Mauro", "affiliation": { "@type": "Organization", "name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy. Electronic address: dimauroernesto8@gmail.com." } }, { "@type": "Person", "name": "Yifu Yu", "url": "https://questionsmedicales.fr/author/Yifu%20Yu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Institute of Molecular Plus, Tianjin University, Tianjin, 300072, China. yyu@tju.edu.cn." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Feasibility of Tablet-Based Remote Data Collection Method for Measuring Hearing Aid Preference.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35914021", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2022_AJA-21-00273" } }, { "@type": "ScholarlyArticle", "name": "Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35608729", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43441-022-00416-x" } }, { "@type": "ScholarlyArticle", "name": "A Data Collection Method for Mobile Wireless Sensor Networks Based on Improved Dragonfly Algorithm.", "datePublished": "2022-05-17", "url": "https://questionsmedicales.fr/article/35619765", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/4735687" } }, { "@type": "ScholarlyArticle", "name": "The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales.", "datePublished": "2023-04-24", "url": "https://questionsmedicales.fr/article/37095636", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dar.13671" } }, { "@type": "ScholarlyArticle", "name": "Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections.", "datePublished": "2023-01-03", "url": "https://questionsmedicales.fr/article/36596462", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-2006-1086" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Acides acycliques", "item": "https://questionsmedicales.fr/mesh/D000144" }, { "@type": "ListItem", "position": 5, "name": "Formiates", "item": "https://questionsmedicales.fr/mesh/D005561" }, { "@type": "ListItem", "position": 6, "name": "Formamides", "item": "https://questionsmedicales.fr/mesh/D005559" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Formamides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Formamides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Formamides", "description": "Comment diagnostiquer une exposition aux formamides ?\nQuels tests sont utilisés pour détecter les formamides ?\nQuels symptômes indiquent une intoxication aux formamides ?\nLes formamides peuvent-ils être détectés par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Formamides", "description": "Quels sont les symptômes d'une exposition aiguë aux formamides ?\nLes formamides provoquent-ils des effets à long terme ?\nComment les formamides affectent-ils la peau ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la voie d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Formamides", "description": "Comment prévenir l'exposition aux formamides ?\nLes travailleurs doivent-ils être formés sur les formamides ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes femmes enceintes doivent-elles éviter les formamides ?\nLes équipements de protection sont-ils obligatoires ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Formamides", "description": "Quel est le traitement principal en cas d'intoxication aux formamides ?\nDes antidotes existent-ils pour les formamides ?\nComment traiter les irritations cutanées causées par les formamides ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition ?\nQuel suivi médical est recommandé après exposition ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Formamides", "description": "Quelles complications peuvent survenir après exposition ?\nLes formamides peuvent-ils causer des cancers ?\nComment les formamides affectent-ils le système nerveux ?\nY a-t-il des risques pour la reproduction ?\nLes effets des formamides sont-ils réversibles ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Formamides", "description": "Qui est le plus à risque d'exposition aux formamides ?\nLes enfants sont-ils plus vulnérables aux formamides ?\nQuels environnements augmentent le risque d'exposition ?\nLes personnes âgées sont-elles à risque ?\nLes allergies augmentent-elles le risque d'effets ?", "url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition aux formamides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les formamides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les formamides." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication aux formamides ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des irritations cutanées." } }, { "@type": "Question", "name": "Les formamides peuvent-ils être détectés par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les formamides, mais peut montrer des effets sur les organes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux formamides." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë aux formamides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées et des irritations respiratoires." } }, { "@type": "Question", "name": "Les formamides provoquent-ils des effets à long terme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des problèmes neurologiques et rénaux." } }, { "@type": "Question", "name": "Comment les formamides affectent-ils la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des irritations cutanées, des rougeurs et des démangeaisons." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes similaires, mais sont plus sensibles aux effets." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la voie d'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inhalation, l'ingestion ou le contact cutané peuvent provoquer des symptômes différents." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux formamides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les formamides ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle pour les travailleurs." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être mises en place ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Installer des systèmes de ventilation et des douches de sécurité dans les zones de travail." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter les formamides ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux formamides peut être nocive pour le fœtus, il faut éviter tout contact." } }, { "@type": "Question", "name": "Les équipements de protection sont-ils obligatoires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le port d'équipements de protection est obligatoire dans les environnements à risque." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication aux formamides ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à retirer la personne de l'exposition et à administrer des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les formamides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour les intoxications aux formamides." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par les formamides ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il est recommandé de rincer la zone affectée à l'eau et d'appliquer des crèmes apaisantes." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires pour l'exposition ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en cas d'exposition sévère, des soins d'urgence sont essentiels pour éviter des complications." } }, { "@type": "Question", "name": "Quel suivi médical est recommandé après exposition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est conseillé pour surveiller les effets à long terme sur la santé." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles respiratoires, neurologiques et rénaux." } }, { "@type": "Question", "name": "Les formamides peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel entre l'exposition aux formamides et certains cancers." } }, { "@type": "Question", "name": "Comment les formamides affectent-ils le système nerveux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles neurologiques, y compris des maux de tête et des vertiges." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition aux formamides peut affecter la fertilité et le développement fœtal." } }, { "@type": "Question", "name": "Les effets des formamides sont-ils réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certains effets peuvent être réversibles, mais d'autres peuvent causer des dommages permanents." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux formamides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des formamides." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux formamides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux effets toxiques des formamides en raison de leur développement." } }, { "@type": "Question", "name": "Quels environnements augmentent le risque d'exposition ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques des formamides." } }, { "@type": "Question", "name": "Les allergies augmentent-elles le risque d'effets ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des allergies peuvent avoir des réactions plus sévères aux formamides." } } ] } ] }

Sources (10000 au total)

Feasibility of Tablet-Based Remote Data Collection Method for Measuring Hearing Aid Preference.

The purpose of this study was to determine the feasibility of a tablet-based remote data collection method for measuring preference for hearing aid signal processing features.... Participants were nine individuals with bilateral mild to moderately severe sensorineural hearing loss. Stimuli were spatialized low-context sentences mixed with six-talker babble at two realistic sig... McNemar's test showed no association between preference and data collection method for the majority of the conditions. Percentage agreement and kappa scores were moderate/fair across most conditions. ... The tablet-based version of remote experimentation was comparable to the lab-based version for eliciting preference for hearing aid signal processing features....

Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials.

Decentralized clinical trials offer the promise of reduced patient burden, faster and more diverse recruitment, and have received regulatory support during the COVID-19 pandemic. However, lack of data... In this article we evaluate the estimation and statistical inference for three scenarios: (1) all onsite measurements, (2) a mixture of onsite and decentralized measurements, and (3) all decentralized... In the mixed modality setting, simulation studies showed that the estimation and inference for the key time points with onsite measurements have good properties and are not impacted by the additional ... Mixed modality trials can help achieve the benefits of decentralized clinical trials by reducing the number of onsite visits with little impact on statistical inferences for various estimands, compare...

The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales.

Standardised data collection processes allow for harmonisation and comparison of data across different studies and services. This project aimed to develop a 'core dataset' to serve as the default coll... A working group was established, comprising clinicians, researchers, data managers and consumers from public sector and non-government organisation AOD services in the NSW Drug and Alcohol Clinical Re... There were 20-40 attendees at each meeting. An initial consensus criterion of having received >70% of the vote was established. Given the difficulty in reaching consensus for most items, subsequently,... This important process received considerable interest and buy-in across the NSW AOD sector. Ample opportunity for discussion and voting was provided for the three domains of interest, allowing partici...

Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections.

As a national effort to better understand the current pandemic, three cohorts collect sociodemographic and clinical data from coronavirus disease 2019 (COVID-19) patients from different target populat... The goal of this work is to assure high consistency of research data mapped to the GECCO data model. In particular, it aims at identifying contradictions within interdependent GECCO data items of the ... All suitable data items from each of the three NAPKON cohorts are mapped to the GECCO items. A consistency assessment tool (dqGecco) is implemented, following the design of an existing quality assessm... Our consistency assessment tool helped in correcting the mapping procedure and reveals remaining contradictory value combinations within COVID-19 symptoms, vital signs, and COVID-19 severity. Consiste... An efficient and portable tool capable of discovering inconsistencies in the COVID-19 domain has been developed and applied to three different cohorts. As the GECCO dataset is employed in different pl...

Essential data dimensions for prospective international data collection in older age bipolar disorder (OABD): Recommendations from the GAGE-BD group.

By 2030, over 50% of individuals living with bipolar disorder (BD) are expected to be aged ≥50 years. However, older age bipolar disorder (OABD) remains understudied. There are limited large-scale pro... We developed initial recommendations for the essential dimensions for OABD data collection, based on (1) a systematic review of measures used in OABD studies, (2) a Delphi consensus of international O... We identified 15 key dimensions and variables within each that are relevant for the investigation of OABD: (1) demographics, (2) core symptoms of depression and (3) mania, (4) cognition screening and ... The essential data dimensions we present should be of use to guide future international data collection in OABD and clinical practice. In the longer term, we aim to establish a prospective consortium ...

Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.

The risks and benefits of medication use in pregnancy are typically established through post-marketing observational studies. As there is currently no standardised or systematic approach to the post-m... This CDE reference framework was developed within the Innovative Medicines Initiative (IMI) ConcePTION project by experts in pharmacovigilance, pharmacoepidemiology, medical statistics, risk-benefit c... The finalised listing of CDEs comprises 98 individual data elements, arranged into 14 tables of related fields. These data elements are openly available on the European Network of Teratology Informati... With this set of recommendations, we aim to standardise PregPV primary source data collection processes to improve the speed at which high-quality evidence-based statements can be provided about the s...

Wearable alcohol monitors for alcohol use data collection among college students: Feasibility and acceptability.

We assessed the feasibility and acceptability of using BACtrack Skyn wearable alcohol monitors for alcohol research in a college student population.... We enrolled n = 5 (Sample 1) and n = 84 (Sample 2) Indiana University undergraduate students to wear BACtrack Skyn devices continuously over a 5-day to 7-day study period. We assessed feasibility in b... All participants were able to successfully use the alcohol monitors, producing a total of 11,504 h of TAC data. TAC data were produced on 567 days of the 602 total possible days of data collection. Th... The high feasibility and acceptability we observed underscore the promise of using BACtrack Skyn wearable alcohol monitors to improve our understanding of alcohol consumption among college students, a...

Five tips for conducting remote qualitative data collection in COVID times: theoretical and pragmatic considerations.

To provide five methodological and pragmatic tips for conducting remote qualitative data collection during the context of the COVID-19 pandemic.... The tips presented in this article are drawn from insights of our own experiences as researchers conducting remote qualitative research and from the evidence from the literature on qualitative methods... Five tips are provided: 1) Pay attention to ethical issues; 2) Identify and select potential participants; 3) Choose the type of remote interview; 4) Be prepared to conduct the remote interview; and 5... Despite the challenges in conducting remote data collection, strengths are also acknowledged and our experience has shown that it is feasible to recruit and interview participants remotely. The discus...